Ramasastry Saira bought MIRM
March 16, 2026 · Form 4 insider transaction
Ramasastry Saira bought 2,000 shares of Mirum Pharmaceuticals, Inc. at $23.51 per share, a transaction worth $47.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
2,000
Price
$23.51
Total value
$47.0K
InsiderRamasastry Saira
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 16, 2026
Filing dateMarch 17, 2026
Shares owned after2,000
OwnershipDirect
10b5-1 planNo
AmendedNo